FDA Approved for Global Export
Allergy
Alpha-Fetoprotein Test (AFP)
Alpha-Fetoprotein Test (AFP)
Amphetamine (AMP)
Approved for Sale in the USA
BACTERIAL
Barbiturate (BAR)
Benzodiazepine (BZD)
Blood Alcohol Concentration (BAC)
Cancer Markers
Carcinoembryonic antigen (CEA)
Chlamydia
Chlamydia
Cholera
Cholesterol
CLIA WAIVED
Cocaine (COC)
Colorectal Cancer
COVID-19
CRP: C Reactive Protein
Dengue Fever
Disposable CPE Shoe Covers
Drug Tests
Ebola
Ecstasy (MDMA)
Endocrine Health
Face Masks
FDA APPROVED
FDA EMERGENCY USE AUTHORIZED
Fecal Occult Blood (FOB)
Fertility
Glucose Rapid
Gonorrhea
Gonorrhea
H-Pylori
Heart Health
HEPATITIS B
Hepatitis B
Hepatitis C
HIV/AIDS
HIV/AIDS
HSV-1 (Herpes Simplex Virus 1)
HSV-1 (Herpes Simplex Virus 1)
HSV-2 (Herpes Simplex Virus 2)
HSV-2 (Herpes Simplex Virus 2)
Immunoglobulin E (Ige)
Infectious Diseases
Influenza A
Influenza B
Malaria
Marijuana (THC)
Menopause
Methadone (MTD)
Methamphetamine (MET)
Mononucleosis
Mononucleosis
Multi-panel Drugs Tests
Myoglobin
Opiate (OPI)
OVER-THE-COUNTER APPROVED
Ovulation
Oxycodone (OXY)
PARASITIC
Phencyclidine (PCP)
POINT-OF-CARE-TEST
Pregnancy
Professional and OTC
Prostate-Specific Antigen (PSA)
Rubber Gloves
STD/STI
Strep A
Syphilis
Syphilis
Thermometers
Thyroid-Stimulating Hormone (TSH)
Tricyclic Antidepressant (TCA)
Troponin
Tuberculosis
Urinalysis Reagent Strips
Urine
Viral
White or Blue Tape Disposable Hazmat Suits
ZIKA Virus
SKU: GL-D-HRDT-COV19
IGG/IGM Antibody Rapid Diagnostics Test (RDT) for COVID 19 (SARS-COV 2 or SARS 2) Venial Blood
Kit of 25 tests: $226.50 $9.060
The COVID-19 Antibody (IgG/IgM) Rapid Test Device utilizes lateral flow technology for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies in whole blood, serum, and plasma. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for SARS-CoV-2 antibodies.
FEATURES
- Clinical Evaluation
- Positive Percent Agreement (PPA): IgG 96.7%; IgM 86.7%; Overall 96.7%
- Negative Percent Agreement (NPA): IgG 98.0%; IgM 99.0%; Overall 97.0%
- Clinical Agreement with Characterized Samples
- Sensitivity: IgG 96.7%; IgM 100%; Combined 100%
- Specificity: IgG 97.5%; IgM 100%; Combined 97.5%
- Results in 10 minutes
MATERIALS SUPPLIED
- 25 sealed pouches, each containing a test cassette, a dropper, and a desiccant
- 1 Buffer
WARNING:
- This test has been authorized by FDA Approved under an EUA for use by authorized laboratories.
- This test has not been FDA cleared or approved.
- This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.
- This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
- Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
- This product is intended for professional use and not for home use.
If you would like to purchase less than 100:
Reviews
There are no reviews yet.